Impact of tapering targeted therapies (bDMARDs or JAKis) on the risk of serious infections and adverse events of special interest in patients with rheumatoid arthritis or spondyloarthritis: a systematic analysis of the literature and meta-analysis

OBJECTIVES: To systematically review the impact of tapering targeted therapies (bDMARDs or JAKis) on the risk of serious infections and severe adverse events (SAEs) in patients with rheumatoid arthritis (RA) or axial spondyloarthritis (axSpA) in remission or low disease activity (LDA) state. MATERIA...

Descripción completa

Detalles Bibliográficos
Autores principales: Vinson, D., Molet-Benhamou, L., Degboé, Y., den Broeder, A., Ibrahim, F., Pontes, C., Westhovens, R., Závada, J., Pham, T., Barnetche, T., Constantin, A., Ruyssen-Witrand, A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7191828/
https://www.ncbi.nlm.nih.gov/pubmed/32349791
http://dx.doi.org/10.1186/s13075-020-02188-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7191828/
https://www.ncbi.nlm.nih.gov/pubmed/32349791
http://dx.doi.org/10.1186/s13075-020-02188-x

Ejemplares similares